Taiwan FDA registration 651862d3bf1e5ace128537d12ee074b7
"Menaris" Otemin allergen-specific IgE diagnostic reagent
TW: “梅納麗斯”歐特敏 過敏原特異性IgE診斷試劑
Taiwan·Risk Class 2·MINARIS MEDICAL AMERICA, INC.·Registered Dec 08, 2010 – Dec 08, 2025ExpiredRegistration details
- Analysis ID
- 651862d3bf1e5ace128537d12ee074b7
- Customs Code
- DHA00602192200
Company information
- Manufacturer
- MINARIS MEDICAL AMERICA, INC.
- Manufacturer Country
- United States
- Authorized Representative
- MED PHAR ENTERPRISE CO., LTD.
Product details
- Intended Use
- OPTIGEN TM diagnostic reagent is used for in vitro semi-quantitative testing of allergen-specific IgE concentrations in human serum.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.5750 Radioallergen adsorption immunoassay system
- Import Information
- import
Dates and status
- Registration Date
- Dec 08, 2010
- Expiry Date
- Dec 08, 2025
About this record
Access comprehensive regulatory information for "Menaris" Otemin allergen-specific IgE diagnostic reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 651862d3bf1e5ace128537d12ee074b7 and manufactured by MINARIS MEDICAL AMERICA, INC.. The authorized representative in Taiwan is MED PHAR ENTERPRISE CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices